BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 16146887)

  • 1. Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine.
    Peled T; Mandel J; Goudsmid RN; Landor C; Hasson N; Harati D; Austin M; Hasson A; Fibach E; Shpall EJ; Nagler A
    Cytotherapy; 2004; 6(4):344-55. PubMed ID: 16146887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linear polyamine copper chelator tetraethylenepentamine augments long-term ex vivo expansion of cord blood-derived CD34+ cells and increases their engraftment potential in NOD/SCID mice.
    Peled T; Landau E; Mandel J; Glukhman E; Goudsmid NR; Nagler A; Fibach E
    Exp Hematol; 2004 Jun; 32(6):547-55. PubMed ID: 15183895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of serum-free ex vivo-expanded hematopoietic stem cells derived from human umbilical cord blood CD133(+) cells.
    Yao CL; Feng YH; Lin XZ; Chu IM; Hsieh TB; Hwang SM
    Stem Cells Dev; 2006 Feb; 15(1):70-8. PubMed ID: 16522164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical ex vivo expansion of cord blood hematopoietic stem and progenitor cells: duration of culture; the media, serum supplements, and growth factors used; and engraftment in NOD/SCID mice.
    Lam AC; Li K; Zhang XB; Li CK; Fok TF; Chang AM; James AE; Tsang KS; Yuen PM
    Transfusion; 2001 Dec; 41(12):1567-76. PubMed ID: 11778074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.
    Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH
    J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of four methods for processing human cord blood and subsequent study of the expansion of progenitor stem cells isolated using the best method.
    Singh K; Srivastava A; Mathur N; Kumar S; Kumar L; Mukhopadhyay A; Konchupillai V
    Cytotherapy; 2009; 11(6):768-77. PubMed ID: 19878063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cotransplantation of ex vivo expanded and unexpanded cord blood units in immunodeficient mice using insulin growth factor binding protein-2-augmented mesenchymal cell cocultures.
    Ong LM; Fan X; Chu PP; Gay FP; Bari S; Ang JM; Li Z; Chen J; Lim SK; Bunte RM; Hwang WY
    Biol Blood Marrow Transplant; 2012 May; 18(5):674-82. PubMed ID: 22240732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial.
    de Lima M; McMannis J; Gee A; Komanduri K; Couriel D; Andersson BS; Hosing C; Khouri I; Jones R; Champlin R; Karandish S; Sadeghi T; Peled T; Grynspan F; Daniely Y; Nagler A; Shpall EJ
    Bone Marrow Transplant; 2008 May; 41(9):771-8. PubMed ID: 18209724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD133+ cell selection is an alternative to CD34+ cell selection for ex vivo expansion of hematopoietic stem cells.
    Kobari L; Giarratana MC; Pflumio F; Izac B; Coulombel L; Douay L
    J Hematother Stem Cell Res; 2001 Apr; 10(2):273-81. PubMed ID: 11359674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo expansion of umbilical cord blood hematopoietic progenitor cells by combinations of cytokines.
    Urashima M; Hoshi Y; Akiyama M; Kamijo M; Kato Y; Akatsuka J; Maekawa K; Matsuzaki M; Ohnishi J; Kaihara C
    Acta Paediatr Jpn; 1995 Apr; 37(2):160-5. PubMed ID: 7540792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effects of cytokines mediated ex vivo expansion on the cell adhesion molecule expression of cord blood hematopoietic stem and progenitor cells].
    Zhai QL; Qiu LG; Liu Y; Li Q; Han JL; Zhou Z; Li X; Ying HG; Han ZC
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Feb; 24(1):7-10. PubMed ID: 12905831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expansion of megakaryocyte precursors and stem cells from umbilical cord blood CD34+ cells in collagen and liquid culture media.
    Shaw PH; Olszewski M; Kletzel M
    J Hematother Stem Cell Res; 2001 Jun; 10(3):391-403. PubMed ID: 11454314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 3 improves the ex vivo expansion of primitive human cord blood progenitor cells and maintains the engraftment potential of scid repopulating cells.
    Rossmanith T; Schröder B; Bug G; Müller P; Klenner T; Knaus R; Hoelzer D; Ottmann OG
    Stem Cells; 2001; 19(4):313-20. PubMed ID: 11463951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial progenitor cells promote efficient ex vivo expansion of cord blood-derived hematopoietic stem/progenitor cells.
    Qu Q; Liu L; Chen G; Xu Y; Wu X; Wu D
    Cytotherapy; 2016 Mar; 18(3):452-64. PubMed ID: 26857234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective role of functionalized single walled carbon nanotubes enhance ex vivo expansion of hematopoietic stem and progenitor cells in human umbilical cord blood.
    Bari S; Chu PP; Lim A; Fan X; Gay FP; Bunte RM; Lim TK; Li S; Chiu GN; Hwang WY
    Nanomedicine; 2013 Nov; 9(8):1304-16. PubMed ID: 23732300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of tetraethylenepentamine, a synthetic copper chelating polyamine, on expression of CD34 and CD38 antigens on normal and leukemic hematopoietic cells.
    Prus E; Peled T; Fibach E
    Leuk Lymphoma; 2004 Mar; 45(3):583-9. PubMed ID: 15160922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chelatable cellular copper modulates differentiation and self-renewal of cord blood-derived hematopoietic progenitor cells.
    Peled T; Glukhman E; Hasson N; Adi S; Assor H; Yudin D; Landor C; Mandel J; Landau E; Prus E; Nagler A; Fibach E
    Exp Hematol; 2005 Oct; 33(10):1092-100. PubMed ID: 16219531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-culture of cord blood CD34(+) cells with human BM mesenchymal stromal cells enhances short-term engraftment of cord blood cells in NOD/SCID mice.
    Fei XM; Wu YJ; Chang Z; Miao KR; Tang YH; Zhou XY; Wang LX; Pan QQ; Wang CY
    Cytotherapy; 2007; 9(4):338-47. PubMed ID: 17573609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.
    Mattia G; Milazzo L; Vulcano F; Pascuccio M; Macioce G; Hassan HJ; Giampaolo A
    Exp Hematol; 2008 Feb; 36(2):244-52. PubMed ID: 18023520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expansion of HPCs from cord blood in a novel 3D matrix.
    Ehring B; Biber K; Upton TM; Plosky D; Pykett M; Rosenzweig M
    Cytotherapy; 2003; 5(6):490-9. PubMed ID: 14660045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.